Amlodipine and Sinus arrhythmia - a phase IV clinical study of FDA data

Summary:

Sinus arrhythmia is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 60+ old, also take Kisqali, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Sinus arrhythmia when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Sinus arrhythmia?

Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle) is found to be associated with 365 drugs and 418 conditions by eHealthMe. Check the latest studies of Sinus arrhythmia.

On Jul, 31, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 75 people (0.02%) have Sinus arrhythmia.

Could Amlodipine cause Sinus arrhythmia?

Among these 75 people:

What is the gender of people who have Sinus arrhythmia when taking Amlodipine? *

female: 73.61 %
male: 26.39 %

What is the age of people who have Sinus arrhythmia when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

What are other side effects people have besides Sinus arrhythmia? *

Fever: 36 people, 48.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 31 people, 41.33%
Atrioventricular Block First Degree (heart block first degree): 29 people, 38.67%
Fatigue (feeling of tiredness): 28 people, 37.33%
Arrhythmias (irregular heartbeat): 28 people, 37.33%
Rashes (redness): 27 people, 36.00%
Nausea (feeling of having an urge to vomit): 23 people, 30.67%
Mitral Valve Incompetence (inefficient heart valve): 22 people, 29.33%
Tricuspid Valve Incompetence (inefficient heart valve): 21 people, 28.00%
Cardiac Valve Sclerosis (heart valve thickness): 20 people, 26.67%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 20 people, 26.67%
Hypertensive Crisis: 19 people, 25.33%
Stress And Anxiety: 11 people, 14.67%
Panic Disorder: 10 people, 13.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 12.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 12.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 8 people, 10.67%
Type 2 Diabetes: 4 people, 5.33%
Asthma: 4 people, 5.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 5.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Sinus arrhythmia?

- Check whether Sinus arrhythmia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,829 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus arrhythmia:

Sinus arrhythmia (365 drugs)

Browse all the conditions that are associated with Sinus arrhythmia:

Sinus arrhythmia (418 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.